Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial, Journal of Clinical Oncology, October 2017, American Society of Clinical Oncology (ASCO),
DOI: 10.1200/jco.2017.72.6463.
You can read the full text:
Contributors
The following have contributed to this page
